365 related articles for article (PubMed ID: 10873604)
1. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
2. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T
Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
[TBL] [Abstract][Full Text] [Related]
5. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA].
Qu Y; Liu S; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313
[TBL] [Abstract][Full Text] [Related]
6. [Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells].
Song DP; Lin JS; Fu GL; Sun XM; Kong XJ; Li PY; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):616-9. PubMed ID: 15504295
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase].
Qu Y; Liu SQ; Peng WZ; Liu BL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445
[TBL] [Abstract][Full Text] [Related]
9. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
11. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
12. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880
[TBL] [Abstract][Full Text] [Related]
14. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
Anticancer Res; 2001; 21(3B):1937-43. PubMed ID: 11497281
[TBL] [Abstract][Full Text] [Related]
15. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
[TBL] [Abstract][Full Text] [Related]
19. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
[TBL] [Abstract][Full Text] [Related]
20. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
